ANN HANHAM
CIK 1286338 · last filed 2025-06-30
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$31.6K
Companies
3
Total Filings
44
Lifetime Open-Market Net
-$5.33M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | 8,703 | $3.63 | $31.6K | $35.4K | 19 | 2025-06-30 |
| HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Director | 41 | $0.48 | $20 | $0 | 8 | 2022-09-15 |
| ENDOCYTE INC (ECYT) Delisted | Director | 62,096 | — | — | -$5.37M | 17 | 2017-05-05 |
Recent Filings · Page 2 of 5
44 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2020-08-21 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-07-08 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2019-08-16 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2019-06-20 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2019-01-04 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2018-09-12 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | +2,304 | $10.0K | EDGAR |
| 2018-08-17 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | +2,500 | $0 | EDGAR |
| 2018-01-04 | SCYX | Grant (A) | — | $0 | EDGAR |
| 2017-08-16 | HTG MOLECULAR DIAGNOSTICS, INC (HTGM) Delisted | Grant (A) | — | $0 | EDGAR |
| 2017-05-05 | ENDOCYTE INC (ECYT) Delisted | Grant (A) | +3,300 | $0 | EDGAR |
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.